Spring Bank Pharmaceuticals, Inc. (SBPH)

Stock Price: $1.47 USD 0.01 (0.68%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
After-hours: $1.54 +0.07 (4.76%) Aug 7, 7:57 PM
PRNewsWire - 2 days ago

NEW ORLEANS, Aug. 6, 2020 /PRNewswire/ -- Former Attorney General of Louisiana Charles C.

PRNewsWire - 3 days ago

NEW YORK, Aug. 5, 2020 /PRNewswire/ --Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New ...

Business Wire - 5 days ago

NEW YORK--(BUSINESS WIRE)-- #Acquisition--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Spri...

PRNewsWire - 1 week ago

NEW YORK, July 31, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH) and its board of director...

Business Wire - 1 week ago

NEW YORK--(BUSINESS WIRE)--Rowley Law PLLC is investigating potential securities law violations by Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH) and its board of directors concerning the pr...

Newsfile Corp - 1 week ago

New York, New York--(Newsfile Corp. - July 30, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To view an enhanced version of this graphic, please visit:https://orders...

GlobeNewsWire - 1 week ago

HOPKINTON, Mass. and CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., July 29, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) (“Spring Bank”), a clinical-stage biop...

GlobeNewsWire - 2 months ago

-    Safety Review Committee for IV SB 11285 Phase 1a/1b trial recommends dose escalation to next planned monotherapy dose level and initiation of first co-administration dose level with Roc...

GlobeNewsWire - 4 months ago

HOPKINTON, Mass., April 02, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology a...

Market Watch - 6 months ago

Spring Bank Pharmaceuticals Inc. [s; sbph] said Wednesday it is scrapping the development of inarigivir soproxil, a treatment for chronic hepatitis B virus, after a patient died during a phase...

GlobeNewsWire - 6 months ago

HOPKINTON, Mass., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatme...

Zacks Investment Research - 7 months ago

The upbeat sentiments prevailing in Wall Street make investment in small caps stocks attractive for 2020, here's why.

Stocks mentioned: CHUY, CUBI, DKL, SBPH, UCTT
Zacks Investment Research - 7 months ago

Spring Bank (SBPH) declines as it stops dosing and enrolling patients in phase IIb studies on inarigivir.

Market Watch - 7 months ago

Spring Bank Pharmaceutical Inc.'s shares slid 17% in premarket trade Thursday, after the clinical-stage biopharma company said it has stopped dosing patients in a trial of a treatment for chr...

GlobeNewsWire - 7 months ago

HOPKINTON, Mass., Dec. 26, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatme...

Zacks Investment Research - 7 months ago

Top Ranked Momentum Stocks to Buy for December 24th

Stocks mentioned: DKS, EVA, JOUT, SBPH
Zacks Investment Research - 7 months ago

As of late, it has definitely been a great time to be an investor in Spring Bank Pharmaceuticals.

Zacks Investment Research - 7 months ago

Top Ranked Momentum Stocks to Buy for December 11th

Stocks mentioned: EXPR, GCO, SBPH, SEAC
GlobeNewsWire - 8 months ago

HOPKINTON, Mass., Nov. 20, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatme...

GlobeNewsWire - 8 months ago

HOPKINTON, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatme...

GlobeNewsWire - 10 months ago

HOPKINTON, Mass., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatm...

GlobeNewsWire - 10 months ago

HOPKINTON, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatm...

Zacks Investment Research - 1 year ago

As of late, it has definitely been a great time to be an investor in Spring Bank Pharmaceuticals, Inc. (SBPH).

Seeking Alpha - 1 year ago

Today, we take an in-depth look at Spring Bank Pharmaceuticals.

Latest From StockTwits